Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.8852 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.10635 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.75337 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.521 | 85 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.10593 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.59178 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.28089 | 86 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.18997 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.35296 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.05544 | 83 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.75507 | 81 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.25908 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.31802 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.10013 | 83 |